MGI DNBSEQ technology, developed by MGI (a subsidiary of BGI Group), represents a revolutionary approach to next-generation sequencing (NGS). It utilizes DNA Nanoball (DNB) technology for highly efficient DNA template preparation, followed by massively parallel sequencing using sequencing by synthesis (SBS) chemistry. DNBSEQ offers unparalleled accuracy, speed, and cost-effectiveness, making it a cutting-edge solution for genomics research, clinical diagnostics, and precision medicine. https://en.mgi-tech.com/products/resources #MGIDNBSEQtechnology